Literature DB >> 10426913

Calciphylaxis associated with metastatic breast carcinoma.

D N Mastruserio1, E Q Nguyen, T Nielsen, A Hessel, A E Pellegrini.   

Abstract

Calciphylaxis is a rare disorder associated with calcification of small- and medium-sized blood vessels, and progressive skin necrosis usually seen in the setting of end-stage renal disease (ESRD) and secondary hyperparathyroidism. It has also been observed in primary hyperparathyroidism, hypercalcemia of malignancy (extensive bony metastasis of breast cancer), and an isolated case reported with end-stage liver disease. We report an unusual case of calciphylaxis associated with metastatic breast carcinoma in the absence of renal or parathyroid disease. Calciphylaxis has generally been associated with end-stage renal disease and hyperparathyroidism. One previous case report described calciphylaxis occurring in a patient with metastatic adenocarcinoma of the breast and hypercalcemia. Our case represents the second reported case of calciphylaxis associated with osteolytic, metastatic breast cancer. Although ESRD with secondary hyperparathyroidism is the most common presentation of calciphylaxis, this case demonstrates that other conditions that alter normal calcium metabolism must be considered in the differential diagnosis.

Entities:  

Mesh:

Year:  1999        PMID: 10426913     DOI: 10.1016/s0190-9622(99)70368-3

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

Review 1.  Calciphylaxis.

Authors:  R V Mathur; J R Shortland; A M el-Nahas
Journal:  Postgrad Med J       Date:  2001-09       Impact factor: 2.401

Review 2.  Calciphylaxis from nonuremic causes: a systematic review.

Authors:  Sagar U Nigwekar; Myles Wolf; Richard H Sterns; John K Hix
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-16       Impact factor: 8.237

3.  Calciphylaxis of the breast, mimicking advanced breast cancer with skin involvement.

Authors:  Joseph T George; Lauren Green
Journal:  Radiol Case Rep       Date:  2021-03-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.